C-I5ISBrainKey
AI, brain MRI, biomarkers
software data
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-I5IS
C-I5ISC-I5ISAI, brain MRI, biomarkers
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Morphine self-administration induces region-specific brain volume changes and microglial phenotypic alterations without affecting neuronal density in male Wistar rats | bioRxiv Skip to main content Home About Submit ALERTS / RSS Search for this keyword Advanced Search New Results Morphine self-administration induces region-specific brain volume changes and microglial phenotypic alterations without affecting neuronal density in male Wistar rats Ana Débora Elizarrarás-Herrera , David Medina-Sánchez , Mariana Stefania Serrano-Ramírez , View ORCID Profile Diego Angeles-Valdez , Luis A. Trujillo-Vi … ppi . 2017 . “ Brain MRI Atrophy Quantification in MS: From Methods to Clinical Application .” Neurology 88 ( 4 ): 403 – 13 . OpenUrl CrossRef PubMed ↵ Rodríguez-Borillo , Olga , Lorena Roselló-Jiménez , Julian Guarque-Chabrera , María Palau- Batet , Isis Gil-Miravet , Raúl Pastor , Marta Miquel , and Laura Font . 2023 . “ Neural Correlates of Cocaine-Induced Conditioned Place Preference in the Posterior Cerebellar Cortex .” Frontiers in Behavioral Neuroscience 17 ( April ):
Wize Pharma Enters Exclusive License Agreement for Ophthalmic Non-viral Gene Therapy Technology Accessibility Statement Skip Navigation Back to Global Sites +972-77-2005042 Blog Journalists GDPR Send a Release News Products Contact Hamburger menu Send a Release Telephone +972-77-2005042 from 8 AM - 11 PM IL Contact Contact +972-77-2005042 from 8 AM - 11 PM IL --> Request More Information Journalists GDPR --> Request More Information Journalists GDPR Request More Information Journalists GDPR Request More Information Journalists GDPR Wize Pharma Enters Exclusive License Agreement for Ophthalmic … . According to the Exclusive License Agreement, at the closing, Copernicus will grant Wize a worldwide exclusive license to develop, manufacture and otherwise to commercialize the technology and patents of Copernicus for the treatment of CHM, with a right of sublicense (subject to the terms of the agreement). Before the closing, the parties agreed, among other things, to negotiate and enter into a mutually acceptable Development Agreement whereby Copernicus will pro … or the development services, Wize agreed to pay Copernicus amounts over time to fund and execute the workplan leading to the completion of a Phase 1/2 clinical study in subjects with Choroideremia as well as development milestone payments. ThinkEquity, a division of Fordham Financial Management, Inc., is acting as financial advisor to Wize Pharma on this transaction. Conference Call Information Wize will host a conference call and live audio webcast with a slide presentation … eden United Kingdom United States Do not sell or share my personal information: Submit via [email protected] Call Privacy toll-free: 877-297-8921 Global Sites Asia Brazil Canada Csezh Denmark Finland France Germany India Israel Italie Mexico Middle East Netherlands Norway Poland Portugal Russia Slovakia Spain Sweden United Kingdom United States +972-77-2005042 from 8 AM - 11 PM IL Terms of Use Privacy Policy Information Security Policy Site Map Cookie Settings Cop
%PDF-1.7 %���� 687 0 obj > endobj 713 0 obj >/Encrypt 688 0 R/Filter/FlateDecode/ID[ ]/Index[687 59]/Info 686 0 R/Length 120/Prev 4393586/Root 689 0 R/Size 746/Type/XRef/W[1 3 1]>>stream h�bbd```b`�X"�~�H�^ɺDr �� �Y L���g`�f`�� R* D CD�e'�Hi�8�2�9�`�H�� H2�\�l���� R� H�����D� ��#�30=0�G� endstream endobj startxref 0 %%EOF 745 0 obj >stream 3�~%G�(go]�Z�$�-�#ɼcX 7��I�YCq�7I��~f���Z.�.(밊 X� ��8�'L��ފ�D��O�p햺v���z�M�'�_� �B؝�>Y�~���o�@DF�. m�?W3�a�tb"�� M$�*="�a���Y��(B��{���7�\��!�[���Ĉ�+�XHU��4w�B�*n�Lss KVa�KG��D�Mo�p��s�?� Ok�Ed(� c�a����&�j�I�ׅ��˰he�C��|
8-K 1 form8k.htm CURRENT REPORT Filed by Automated Filing Services Inc. (604) 609-0244 - Cyberkinetics Neurotechnology Systems, Inc. - Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 7, 2004 Cyberkinetics Neurotechnology Systems, Inc. (Exact name of registrant specified in charter) Delaware 000-50505 13-4287300 (State of (Commission File (IRS Employer Incorporation) Number) Id … ge the NeuroPort™ device for data collection and analysis in a closed loop application. Market Opportunity . Cyberkinetics' first generation devices are designed to restore functionality for a limited, immobile group of severely motor-impaired patients who suffer from spinal cord injury, severe stroke, muscular dystrophy and Amyotrophic Lateral Sclerosis ("ALS"). Cyberkinetics believes that there are approximately 400,000 individuals in the U.S. with paralyzed limbs, and … lent to other products that are already on the market. Cyberkinetics intends to submit a 510(k) application to the FDA before the end of 2004. Clinical Trials . Cyberkinetics has received an IDE from the FDA to conduct a pilot clinical trial of the BrainGate™ system. This trial is currently in process and it is designed to demonstrate both the safety and the feasibility of a thought-based interface with a personal computer, which can replace the use of hands on a keyboar … nificant additional clinical studies must be completed before Cyberkinetics can apply to the FDA for permission to make specific safety and efficacy claims related to the BrainGate™ system. Employees. At August 31, 2004, Cyberkinetics employed 32 full-time employees. Approximately 23 of its employees are involved in research and clinical development activities. Five of Cyberkinetics' employees hold Ph.D. or M.D. degrees. Cyberkinetics believes that its relationship with … humanitarian device exemption ("HDE") rather than through a pre-market approval application ("PMA"). Approval of an HDE by the FDA requires that Cyberkinetics demonstrate that the BrainGate TM system is safe, potentially effective and that its benefits outweigh its associated risks. The FDA has not yet designated the BrainGate TM system as approp
Barrow researchers are... - Barrow Neurological Institute Facebook Log In Barrow Neurological Institute's Post Barrow Neurological Institute Verified account April 30 · Shared with Public Barrow researchers are dreaming big with big data—and now they have a bigger space to match. The Barrow Neuro Analytics Center at Park Central Phoenix in the #PhoenixMedicalQuarter has nearly doubled its footprint, adding 8,317 square feet to its existing 10,099-square-foot facility. Launched in 2024, the #BarrowNeuroAnalyticsCenter combines advanced computational and statistical methods, immense computi
Frontiers | Vitamin D, Homocysteine, and Folate in Subcortical Vascular Dementia and Alzheimer Dementia Frontiers in Aging Neuroscience About us About us Who we are Mission and values History Leadership Awards Impact and progress Frontiers' impact Our annual reports Thought leadership Publishing model How we publish Open access Quality and research integrity Peer review Research Topics Publish your data Fee policy Services Societies National consortia Institutional partnerships Collaborators More from Frontiers Frontiers Forum Frontiers Planet Prize Press office Sustainability Career oppor … office Sustainability Career opportunities Contact us All journals All articles Submit your research Search Frontiers in Aging Neuroscience Sections Sections Aging Neuroscience Archive Alzheimer's Disease and Related Dementias Cellular and Molecular Mechanisms of Brain-aging Neurocognitive Aging and Behavior Neuroinflammation and Neuropathy Parkinson’s Disease and Aging-related Movement Disorders Articles Research Topics Editorial board About journal About journal Scope F … rnal sections Open access statement Copyright statement Quality For authors Why submit? Article types Author guidelines Editor guidelines Publishing fees Submission checklist Contact editorial office About us About us Who we are Mission and values History Leadership Awards Impact and progress Frontiers' impact Our annual reports Thought leadership Publishing model How we publish Open access Quality and research integrity Peer review Research Topics Publish your data Fee p … partnerships Collaborators More from Frontiers Frontiers Forum Frontiers Planet Prize Press office Sustainability Career opportunities Contact us All journals All articles Submit your research Frontiers in Aging Neuroscience Sections Sections Aging Neuroscience Archive Alzheimer's Disease and Related Dementias Cellular and Molecular Mechanisms of Brain-aging Neurocognitive Aging and Behavior Neuroinflammation and Neuropathy Parkinson’s Disease and Aging-related Movement D … rnal sections Open access statement Copyright statement Quality For authors Why submit? Article types Author guidelines Editor guidelines Publishing fees Submission checklist Contact editorial office Frontiers in Aging Neuroscience Sections Sections Aging Neuroscience Archive Alzheimer's Disease and Related Dementias Cellular and Molecular Me
sava-20221231x10k false FY 0001069530 Yes Yes No Yes 2037-12-31 2029-01-01 2026-12-31 2042-12-31 2024-01-01 0001069530 srt:MinimumMember sava:ExpirationResearchAndDevelopmentTaxCreditsMember us-gaap:DomesticCountryMember us-gaap:ResearchMember 2022-01-01 2022-12-31 0001069530 srt:MaximumMember sava:ExpirationResearchAndDevelopmentTaxCreditsMember us-gaap:DomesticCountryMember us-gaap:ResearchMember 2022-01-01 2022-12-31 0001069530 sava:ExpirationResearchAndDevelopmentTaxCreditsMember us-gaap:DomesticCountryMember us-gaap:ResearchMember 2022-12-31 0001069530 us-gaap:RetainedEarningsMember 2022- … eding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  þ No  ¨ . Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth c … ur operations;  the sufficiency of our current resources to continue to fund our operations;  potential future agreements with third parties in connection with the commercialization of our product candidates;  the accuracy of our estimates regarding expenses, capital requirements, and needs for additional financing;  assumptions and estimates used for our disclosures regarding stock-based compensation;  the expense, timing and outcome o … zheimer’s disease.  This study was funded in part by a research grant award from NIH. The study was designed to evaluate the long-term safety and tolerability of simufilam 100 mg twice daily for 12 or more months. Another study objective was to assess exploratory efficacy endpoints, such as changes in cognition, and biomarkers. In January 2023, we announced positive top-line Phase 2 results for our open-label study. The study enrolled over 200 patien … l-controlled studies in support of a future regulatory submission and marketing application. The first clinical study protocol under the SPA is titled “ A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 52-Week Study Evaluating the Safety and Efficacy of One Dose of Simufilam in Subjects with Mild-to-Moderate Alzheime
Social and Physical Environments Influence the Rate of Brain Aging and Dementia Risk | Global Brain Health Institute Skip to main content Apply to Atlantic Fellowship for Equity in Brain Health Fellows Directory Search Search open menu open menu About Who We Are Who We Are The Global Brain Health Institute (GBHI) is dedicated to protecting the world’s aging populations from threats to brain health. UCSF & Trinity Collaboration UCSF & Trinity Collaboration The University of California, San Francisco (UCSF) and Trinity College Dublin (Trinity) have formed a strong partnership based on sh … in philanthropy to secure the long-term sustainability of this unique program. Fellowship About the Fellowship Program About the Program The Atlantic Fellows for Equity in Brain Health program provides innovative training, networking, and support to emerging leaders focused on improving brain health and reducing the impact of dementia. Program Experience Program Experience The program experience is designed to provide fellows with experiences that build knowledge, enhance sk … but enriched by the unique aspects and expertise of UCSF and Trinity. Lifelong Fellowship Lifelong Fellowship Becoming an Atlantic Fellow for Equity in Brain Health doesn’t end on completion of the program. Apply to Fellowship FAQs French Fondation Alzheimer Atlantic Fellowship Apply to Fellowship The Atlantic Fellows for Equity in Brain Health program is an opportunity to elevate your impact and contribution to brain health. Postdoctoral Program in Brain Health Equity Postd … reduce the impact of dementia. Learn more About Our Mission Contact Us Sitemap Fellowship Program Apply to Fellowship GBHI at UCSF GBHI at Trinity Network Fellows Directory Alumni Atlantic Institute Privacy Policy Intranet All contents © Global Brain Health Institute. All rights reserved. Off-canvas navigation About Who We Are UCSF & Trinity Collaboration Annual Reports Work With Us Our Approach The Global Problem Our Impact Equity and Brain Health Protect Your Brain Hea … lty Expertise Partners & Collaborators Atlantic Fellows Programs Support Us Fellowship About the Fellowship Program Program Experience Approach to Learning Content and Structure Curriculum Leadership Mentorship Clinical and Lived Experiences Site Opportunities Lifelong Fellowship Apply to Fellowship FAQs French Fondation Alzheimer Atlantic Fe
Brain trust – our product review of BrainKey Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Leal Therapeutics doses fir... AnHorn’s nerve-pr
FAQs | BrainKey FAQ Contact Us Log In About Team Partners FAQ Contact Us Log In Frequently Asked Questions Learn more about BrainKey. Why did you start BrainKey? What is BrainKey? Contact Us About Our Team Our Partners 3D Print Your Brain Log In Get Started Learn Publications Support FAQ Contact Us Trust Center Legal Privacy Policy HIPAA Terms of Service About Home Our Team Our Partners Get A BrainKey MRI Scan 3D Print Your Brain Log In Get Started Learn Publications Support FAQ Contact Us Trust Center Legal Privacy Policy HIPAA Terms of Service Copyright © 2026 Brain Key Inc. All Rights Reser
PLOS ONE Publishes Clinical Study Results and EEG Data Showing Akili Digital Therapeutic EndeavorRx ® Activates Systems in Brain Key to Attentional Functioning — Akili Interactive Science & Tech Products Blog Join Us News Contact Back Overview Product Development COVID Brain Fog 2023 ADHD in Workplace Report Publications Back Careers at Akili Science & Tech Overview Product Development COVID Brain Fog 2023 ADHD in Workplace Report Publications Products Blog Join Us Careers at Akili News Contact PLOS ONE Publishes Clinical Study Results and EEG Data Showing Akili Digital Therapeutic Endea … hat the proposed transaction may not be completed by SCS’s business combination deadline and the potential failure to obtain an extension of the business combination deadline if sought by SCS, (iii) the failure to satisfy the conditions to the consummation of the proposed transaction, including the adoption of the Merger Agreement by the shareholders of SCS and the satisfaction of the minimum cash condition, (iv) the lack of a third party valuation in determining whether or n
10-K 1 sava-20201231x10k.htm 10-K 20201231 10K   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________  Form 10-K _______________   (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 20 20 or  ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 000-29959  Cassava Sciences, … eding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐ . Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” a … ical facilities; · the sufficiency of our current resources to continue to fund our operations; · the accuracy of our estimates regarding expenses, capital requirements, and needs for additional financing; · assumptions and estimates used for our disclosures regarding stock-based compensation; and · the long-term impact of COVID-19, a novel coronavirus first detected in 2019, on our operations and financial condition.  We cannot assure you that we … on key elements of a pivotal Phase 3 clinical program in support of a New Drug Application (NDA) filing for simufilam in Alzheimer’s disease. We believe agreements reached during the EOP2 meeting show a clear path forward for advancing simufilam into Phase 3 studies . We expect to initiate a pivotal Phase 3 program with simufilam in Alzheimer’s disease in the second half of 2021.  Our diagnostic effort, called SavaDx, is an early-stage program focused o … for 28 continuous days. This study was substantially funded by a research grant award from NIH.  In September 202 0, we reported positive final study results for our Phase 2b study. Drug was safe and well-tolerated. Simufilam significantly (P<0.05) improved an entire panel of validated biom
Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.
Arteries of the Brain: Key Components of Circulation - Neurotorium About us 3D Brain Atlas Outreach & Partnerships Clinical Education Grants Contact Login Search Search AI-based search on Neurotorium Ask Neurotorium's AI-based search bot Toggle search Neurobiology Epilepsy Anxiety Depression Parkinson’s Bipolar All themes Search for: Neurobiology Epilepsy Anxiety Depression Parkinson’s Disease Bipolar Disorder All themes About us 3D Brain Atlas Outreach & Partnerships Clinical Education Grants Contact Login Ask Neurotorium Image Arteries of the brain Fundamentals of Neurobiology
Microsoft and BrainKey partner on AI for brain scans | Jemal Dents posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to
Events for January 13, 2026 › Educational › – La Grange Business Association La Grange Farmers Market About 2026 Board & Staff Businesses & Amenities Student Scholarships & Internships La Grange Events Gift Certificates Member Login Becoming a Member Member Calendar Getting Around Blog Member Login Businesses and Amenities La Grange Events Member Calendar Becoming a Member Student Scholarships & Internships Parking and Transportation La Grange Business Association Craft Fair Farmers Market Now Hiring in La Grange CRM & Website Operations Intern (Summe … All Ages Chase away the winter chill! Complete six reading activities to earn a prize packet and a ticket for our amazing prize baskets. Want to turn up the heat? Complete all the activities to earn an additional ticket for the baskets! Register on Beanstack to participate online, or grab a paper […] 10:30 am The Neurological Perspective of Music, Memory, and the Brain January 13 @ 10:30 am Ascension Living Bethlehem Woods Village 1571 Ogden Avenue, La Grange Park Join
Drug transport to the brain: key roles for the efflux pump P-glycoprotein in the blood-brain barrier Drug transport to the brain: key roles for the efflux pump P-glycoprotein in the blood-brain barrier Vascul Pharmacol . 2002 Jun;38(6):339-48. doi: 10.1016/s1537-1891(02)00201-x. Authors Michel Demeule 1 , Anthony Régina , Julie Jodoin , Alain Laplante , Claude Dagenais , France Berthelet , Albert Moghrabi , Richard Béliveau Affiliation 1 Laboratoire de Médecine Moléculaire, Hôpital Sainte-Justine-Université du Québec à Montréal, C.P. 8888, Succu
Partners and Collaborators | BrainKey FAQ Contact Us Log In About Team Partners FAQ Contact Us Log In Our Collaborators Our research partners helping to drive BrainKey forward. Interested in becoming a partner? Contact Us About Our Team Our Partners 3D Print Your Brain Log In Get Started Learn Publications Support FAQ Contact Us Trust Center Legal Privacy Policy HIPAA Terms of Service About Home Our Team Our Partners Get A BrainKey MRI Scan 3D Print Your Brain Log In Get Started Learn Publications Support FAQ Contact Us Trust Center Legal Privacy Policy HIPAA Terms of Service Copyright © 2026
Brain Key Stock Price, Funding, Valuation, Revenue & Financial Statements Technology Vendors Recent Research Newsletter Media Support Login Who We Serve Function Corporate Strategy Corporate Venture Capital Venture Capital IT Corporate Innovation How VCs Use CB Insights Go to the video gallery → Industries Consumer & Retail Tech Insurance Healthcare Industrials Financial Services Professional Services Professional Services Learn More → Success Stories How We Help Understand Tech Markets Anticipate Competitor Strategy Determine Tech Strategy Connect with Tech Vendors & Partners Turb … nia Soma Capital Subscribe to see more Venture Capital California Longevitytech.fund Subscribe to see more Venture Capital Czech Republic Microsoft for Startups Pegasus Program Subscribe to see more Incubator/Accelerator Washington First funding 4/12/2019 00/00/0000 Last Funding 4/12/2019 00/00/0000 Investor Social Starts Y Combinator Soma Capital Longevitytech.fund Microsoft for Startups Pegasus Program Rounds 1 Convertible Note Subscribe to see more Subscribe to see more Su
Mt. Si Senior Center - MSSC Blog 425-888-3434 Home Information ↓ About Us Lunch Housing Links & Resources Local Assistance MSSC Blog Newsletter & Press Snoqualmie Valley Transportation (SVT) VSHSL Wellness Work at MSSC Activities ↓ Activities Adult Fitness Military Women's Memorial Project Photo Albums Support Cookies Corporate Matching Donate Membership 2026 Monthly Giving Making an Impact Volunteer Community Needs Assessment 2026 Flower Baskets Loan Equipment Facility Rentals Five Minutes a Day Could Add Years to Your Life 6/24/2026 0 Comments Here is some genuinely good news! You do
- YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
DBS for LTP: A New Strategy for Parkinson's? | Michael S Okun posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to … ng to Identify Disease Subtypes in Multiple Sclerosis: “Our results support the application of machine learning (ML) in multiple sclerosis (MS), and this is a first big step. [The findings] demonstrated that ML can identify subtypes and stages of MS starting from MRI data. Also, [the study] supports the novel hypothesis of MS as a continuum, more than a distinct disease between relapsing and progressive." https://lnkd.in/e2Xxn-Vv Using MRI-Machine Learning to Identify Disease
BrainKey - Focus & Block Apps App - App Store for iPhone iPhone iPad Mac Vision Watch TV Search Today Games Apps Arcade Platform iPhone iPad Mac Vision Watch TV BrainKey - Focus & Block Apps Stay focused together Only for iPhone Free · In‑App Purchases · Designed for iPhone. Not verified for macOS. Share Age Rating 4+ Years Category Productivity Developer START.IT Language EN English Size 133.4 MB iPhone BrainKey helps you stay focused by blocking distracting apps and connecting you with others who are focusing at the same time. BLOCK DISTRACTIONS Select the apps that distract you mos
Unlocking the brain key to finding a cure for Alzheimer's disease | OpEd - Max Planck Florida Institute for Neuroscience Skip to content About Us About Us Max Planck Florida Institute for Neuroscience is changing the world by unlocking critical new information into how the brain works, from the smallest molecules to incredibly complex synaptic networks. We’re accelerating advances in brain health through breakthrough discoveries and cutting-edge technology, while cultivating the next generation of innovators through education, outreach, and open collaboration. See Overview Mission and Vis … ting-edge discoveries are born. See All Events Scientific Events Sunposium PGYI Award Seminars Special Workshops NeuroMEETs Community Events Science Meets Music Brain Exploration Day Images of Science Events for Students and Teachers Max Brain Challenge Scientific Events Sunposium PGYI Award Seminars Special Workshops NeuroMEETs Community Events Science Meets Music Brain Exploration Day Images of Science Events for Students and Teachers Max Brain Challenge Support Us Make an … ting-edge discoveries are born. See All Events Scientific Events Sunposium PGYI Award Seminars Special Workshops NeuroMEETs Community Events Science Meets Music Brain Exploration Day Images of Science Events for Students and Teachers Max Brain Challenge Scientific Events Sunposium PGYI Award Seminars Special Workshops NeuroMEETs Community Events Science Meets Music Brain Exploration Day Images of Science Events for Students and Teachers Max Brain Challenge Support Us Make an
00 d : 00 h : 00 m : 00 s AI Growth Summit: 9 Tactics to Add $10m Fast | June 30 121/150 seats taken Save Your Seat Home SaaS Database Add Your Company Podcast Pricing Sections Company Revenue Valuation and Funding Founder and CEO Employees and Team Size FAQ Contacts Competitors SaaS Database / Industries / Other Analytics Software / BrainKey BrainKey San Francisco , California , United States brainkey.ai Other Analytics Software Y Combinator Valuation $15M 2024 Revenue $5M (Est.) Funding $0 Team 11 Founded 2018 Company Revenue Valuation and Funding Founder and CEO Employees and Team Size FAQ
#424 – The Wire - The Imaging Wire Skip to content Your work email Subscribe Thank you! Please check your email for confirmation. Something went wrong, please try again. Top Stories Newsletters Shows Sponsor Your work email Subscribe Thank you! Please check your email for confirmation. Something went wrong, please try again. Subscribe Subscribe Thank you! Something went wrong. #424 – The Wire June 5, 2022 Jake Fishman 4 min read BrainKey Adds Genetics: BrainKey added genetics to its unique AI-based brain health analysis platform, joining its existing brain MRI and demographic analysis capabili
Lifeboat Foundation Bios: Professor Evelyne Yehudit Bischof Skip to content Lifeboat Foundation: Safeguarding Humanity About Blog Boards Programs Reports Papers Donate Join Us Newsletter Quotes Store Press Releases Toggle sitemap Lifeboat Foundation Sitemap icon-search Main Areas Home About Boards Blog Programs Reports Papers Donate Join Us Newsletter Quotes Store Press Releases Current Programs AIShield AsteroidShield BioShield InfoPreserver InternetShield LifePreserver LifeShield Bunkers NanoShield ScientificFreedomShield SecurityPreserver Space Habitats X-Risks Network Cool Places A-PRIZE A … gs Outreach Partnerships Rosetta@Home Volunteer Work About Us Bitcoin Endowment Fund Boards Board of Directors Contact Us Donor List FAQ Finances Guardian Award Interactive Friendly AI Logo Memorial Board Mission Statement Procedures Staff Supplemental FAQ Timeline More Programs AlienShield AntimatterShield BioPreserver BlackHoleShield ClimateShield CommPreserver EnergyPreserver GammaRayShield NeuroethicsShield NuclearShield ParticleAcceleratorShield PersonalityPreserver Seed … of the Visionary Board at the Longevity Science Foundation . Read $1B longevity fund launches to pursue 120+ lifespan . One of the main focuses of the Longevity Science Foundation is to drive longevity medicine from theoretical concepts to real-world applications. They support the transformation of scientific findings and deep technological advances into treatments and solutions that can be used in the clinic today. Holmusk is building the largest Real-World Evidence platform … e And The Rise Of The Longevity Physician and Scientists publish a blueprint to apply artificial intelligence to extend human longevity . Watch BrainKey Talks — Episode 3 with Eva , Advancing The Frontiers Of Preventative And Precision Longevity Medicine , and Meet Evelyne Bischof, MD Calling it in From Shanghai This Week on Talk Fast Listen Slow . Visit her LinkedIn profile and her ResearchGate page . Follow her on Facebook , Instagram , and X . Member of Biotech/Medic
Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.
CPA Fall Symposium: Psychedelic Assisted Therapy (7) Menu For Psychologists Join CPA State Licensure Info Prescribing Psychologists RxP Lobbying & Legislation Advocacy Updates Current Action Alerts APA Federal Advocacy Updates Career Center Resources CE Tracker Attorney List Donate to the CPA PAC (Political Action Committee) For the Public Find a Psychologist Disaster Resource Network Advertise with CPA For Students COPAGS Diversity Mentorship Program State Licensure Information Internship Questions News Events Calendar of Events CE Requirements & Approval Learning Center Member Center
BrainKey uses AI and Azure to diagnose brain conditions with MRI scans. | Patricia (Patty) Martone Carrolo posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking C … Technologies Inc. 2,719 followers 9mo Edited Report this post The most profound application of Generative AI in healthcare is happening in the foundational data infrastructure. We are focused on the massive opportunity to use AI to automate the manual process of finding and sharing critical patient data, fixing foundational interoperability challenges. Our Smart Search solution does this with an AI trained on over 50 million radiology procedures, giving it a deep understandin
Turn Brain Scans into Actionable Insights | BrainKey FAQ Contact Us Log In About Team Partners FAQ Contact Us Log In AI for Brain MRI BrainKey is dedicated to developing AI to examine MRI scans to uncover key biomarkers and assess brain health at a biological level. Get Started Owen Philips, PhD Neuroscientist Founder & CEO “A personal health experience in my own family showed me how difficult it can be for anyone to understand the complex data in their medical images. We created BrainKey to build a tool that empowers people by turning that data into clear, intuitive visualizations of thei
Brain Key - Employer Overview, H1B Visas, Green Cards, Salaries, Jobs, Contacts & Reviews | MyVisaJobs sign in | join Visas H-1B Visa Green Card Student Visa All Visas Databases Immigration Attorneys/Firms Candidates (Applicants) Employers (Sponsors) E-Verified Employers Green Card Jobs H-1B Visa Jobs Wage Determinations For Employers Find Candidates Post Jobs Employer Membership Chart Sign In Sign Up For Candidates Find Sponsors Submit Resume Membership Benefit Chart Sign In Sign Up Reports H-1B Visa Green Card All Reports About Blogs FAQ Press Releases Media Coverage Contact Us Search Databa … Brain Key can hire foreign workers, whether permanently or temporarily, it must submit labor certifications to the Department of Labor (DOL). These certifications confirm compliance with wage requirements for the specified job locations.The reports below summarize Labor Condition Applications (LCA) for H-1B visas and Labor Certifications (LC) for green cards filed by Brain Key. This data represents only the number of applications submitted and does not guarantee visa approval … a review about Brain Key ! You are welcome to share your working, interview or application experience with Brain Key Inc. as well as its owners or employees. Please avoid mentioning any names or using profanity and obscene languages when you are making comments. Many of the reviews about H1B visa and green card sponsors on our web site are negative. Though this somewhat reflects one aspect of real immigrant labor market, you should do more research and use your own judgment … illful failure or a misrepresentation of a material fact of the Labor Condition Application (LCA) attestations, please do not post your review here. You should contact Dept of Labor, Dept of Justice or U.S. Immigration and Customs Enforcement (ICE). For additional information, visit DOL Wage and Hour Division Website: http://www.wagehour.dol.gov and/or call their toll-free information and helpline, available 8 a.m. to 5 p.m. in your time zone, 1-866-4USWAGE (1-866-487-9243).
Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.
Turn Brain Scans into Actionable Insights | BrainKey FAQ Contact Us Log In About Team Partners FAQ Contact Us Log In AI for Brain MRI BrainKey is dedicated to developing AI to examine MRI scans to uncover key biomarkers and assess brain health at a biological level. Get Started Owen Philips, PhD Neuroscientist Founder & CEO “A personal health experience in my own family showed me how difficult it can be for anyone to understand the complex data in their medical images. We created BrainKey to build a tool that empowers people by turning that data into clear, intuitive visualizations of thei
Privacy Policy | BrainKey FAQ Contact Us Log In About Team Partners FAQ Contact Us Log In Privacy Policy Privacy Highlights These "Privacy Highlights" provide an overview of some core components of our data handling practices. Please be sure to review the full Privacy Policy (see below). HIPAA Compliance Brain Key aims to provide you the same privacy rights and protections that you would receive from any entity bound by the Health Insurance Portability and Accountability Act (HIPAA), such as your doctor. You can review your rights under HIPAA here . Information We Collect We generally collect … quests (e.g., referrals); enable and enhance your use of our website and mobile application(s), including authenticating your visits, providing personalized content and information, and tracking your usage of our Services; contact you about your account, and any relevant information about our Services (e.g. policy changes, security updates or issues, etc.); enforce our Terms of Service and other agreements; monitor, detect, investigate and prevent prohibited or illegal behavi … tities on genetic research initiatives, or otherwise create, commercialize, and apply this new knowledge to improve health care. BrainKey Research uses Aggregate and/or Individual-level Imaging Information and Self-Reported Information as specified in the appropriate Consent Document(s), as explained in greater detail below. Withdrawing your Consent. You may withdraw your consent to participate in BrainKey Research at any time by changing your consent status within your Accou … ess to your BrainKey account, in certain circumstances, we may require that you submit additional information sufficient to verify your identity before providing access or otherwise releasing information to you. If you choose not to submit the required documentation, or the information provided is not sufficient for the purposes sought, BrainKey will not be able to sufficiently verify your identity in order to complete your request. You may access, correct or update most of y … Contact Information If you have questions about this Privacy Policy, or wish to submit a complaint, please email [email protected] , or send a letter to the address found at the beginning of the Terms of Service : *This Privacy Policy was last updated on February 14, 2020. About Our Team Our Partners 3D Print Your Brain Log In Get Started Le
We are exceptionally grateful to... - Neuroimmune Foundation Facebook Log In Neuroimmune Foundation's Post Neuroimmune Foundation May 11, 2023 · Shared with Public We are exceptionally grateful to our 2023 Inflammatory Brain Disorders Conference sponsor, UW Health . We are looking forward to a great conference next week. For details: https://neuroimmune.org/.../inflammatory-brain-disorders.../ All reactions: 27 3 comments 41 shares Like Comment Most relevant Kelly Lynn Mcadams Sargent Cheri Cirino 3y Ulsa Von Hunter Karla Paravani Alvarenga 3y Ulsa Von Hunter Sandy Dennis 3y
Turn Brain Scans into Actionable Insights | BrainKey FAQ Contact Us Log In About Team Partners FAQ Contact Us Log In AI for Brain MRI BrainKey is dedicated to developing AI to examine MRI scans to uncover key biomarkers and assess brain health at a biological level. Get Started Owen Philips, PhD Neuroscientist Founder & CEO “A personal health experience in my own family showed me how difficult it can be for anyone to understand the complex data in their medical images. We created BrainKey to build a tool that empowers people by turning that data into clear, intuitive visualizations of thei
Turn Brain Scans into Actionable Insights | BrainKey FAQ Contact Us Log In About Team Partners FAQ Contact Us Log In AI for Brain MRI BrainKey is dedicated to developing AI to examine MRI scans to uncover key biomarkers and assess brain health at a biological level. Get Started Owen Philips, PhD Neuroscientist Founder & CEO “A personal health experience in my own family showed me how difficult it can be for anyone to understand the complex data in their medical images. We created BrainKey to build a tool that empowers people by turning that data into clear, intuitive visualizations of thei
Stanford Symposium on AI Medicine: Applications in Oncology, Image-guided Interventions, and Beyond - Stanford Center for Continuing Medical Education - Continuing Education (CE) <strong>Location:</strong></p><p><span style="color: rgb(105, 105, 105); font-family: &quot;Source Sans Pro&quot;, Tahoma, sans-serif; font-size: 14.6667px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-s … Forgot Your Password? Forgot Your Password? Enter your Email address and click submit to have a login reset link sent to you. Back to Login {1} ##LOC[OK]## {1} ##LOC[OK]## ##LOC[Cancel]## {1} ##LOC[OK]## ##LOC[Cancel]## Create an Account: (All fields are required) Email: First Name: Last Name: Password: Password: Password Requirements Must be between 8 and 16 characters in length Must Contain at least 1 upper case character Must Contain at least 1 lower case character Must c … rship on Advisory Committees or Review Panels, Board Membership, etc.-Brain Key|Grant or research support-GE Healthcare Bio-Sciences|Grant or research support-Philips Medical Systems, Inc. Xianjin Dai, Other Clinical Assistant Professor Stanford Faculty Nothing to disclose Issam El Naqa, PhD Chair Moffitt Faculty Nothing to disclose Jason Freeman Stanford Faculty Nothing to disclose Michael Francis Gensheimer, MD Clinical Associate Professor Stanford Faculty Grant or research … hD Google, Inc. Faculty Nothing to disclose Ruijiang Li, Other Stanford Faculty Grant or research support-Sanofi-Aventis Zhuoming Li, other Meta Faculty Nothing to disclose lianli liu, PhD Stanford Faculty Nothing to disclose Sheng Liu, PhD Stanford Faculty Nothing to disclose Erqi Liu Liu Pollom, MD Associate Professor, Interim Medical Director Stanford Faculty Nothing to disclose Matt Lungren, MD Associate Professor of Radiology Microsoft Faculty Nothing to disclose Nigam S … Care Faculty Nothing to disclose Kundan Thind, PhD Henry Ford Hospital Faculty Grant or research support-Varian medical systems |Honoraria-Varian medical systems |Other: Travel support-Varian medical systems Gilmer Valdes, PhD Moffitt Faculty Nothing to disclose David JH Wu, MD Stanford Faculty Nothing to disclose Rui (Rachel) Yan, PhD Stanford
Terms of Service | BrainKey FAQ Contact Us Log In About Team Partners FAQ Contact Us Log In Terms of Service 1. Definitions "BrainKey" means Brain Key, Inc., whose principal place of business is at 218 9th Street, San Francisco, CA 94103. "BrainKey Research" means scientific research that BrainKey performs with the intent to publish in a peer-reviewed scientific journal. BrainKey Research only uses Imaging and Self-Reported Information from users who have given informed consent according to the applicable Consent Document. BrainKey Research activities do not include R&D. "Product Developme … forth in these Terms of Service ("TOS"). Except as specified herein, these TOS apply to any use of the Services, including but not limited to a) creating an account, uploading a digital version of your Imaging Information and interacting with it on the BrainKey website, and/or b) using a BrainKey account without providing your Imaging Information. In order to use the Services, you must first agree to the TOS. You may not use the Services if you do not accept the TOS. You can … e that are governed by different terms of service. 3. Prerequisites Whether you submit your own Imaging Information or Imaging Information for anyone for whom you have legal authority to agree, you may not use the Services and may not accept the TOS if (1) you are not of legal age to form a binding contract with BrainKey, or (2) you are a person barred from receiving the Services under the laws of the jurisdiction in which you are resident or from which you use the Services. … ed in our service rely on these published studies, some interpretations may not apply to you. Future scientific research may change the interpretation of your brain scans. In the future, the scientific community may show previous research to be incomplete or inaccurate. Imaging Information you share with others could be used against your interests. You should be careful about sharing your Imaging Information with others. Currently, very few businesses or insurance companies r … tities on imaging research initiatives, or otherwise create, commercialize, and apply this new knowledge to improve health care. BrainKey will never release your individual-level Imaging Information and/or Self-Reported Information to any third party without asking for and receiving your explicit consent to do so, unless required by law. Further,
Turn Brain Scans into Actionable Insights | BrainKey FAQ Contact Us Log In About Team Partners FAQ Contact Us Log In AI for Brain MRI BrainKey is dedicated to developing AI to examine MRI scans to uncover key biomarkers and assess brain health at a biological level. Get Started Owen Philips, PhD Neuroscientist Founder & CEO “A personal health experience in my own family showed me how difficult it can be for anyone to understand the complex data in their medical images. We created BrainKey to build a tool that empowers people by turning that data into clear, intuitive visualizations of thei
Turn Brain Scans into Actionable Insights | BrainKey FAQ Contact Us Log In About Team Partners FAQ Contact Us Log In AI for Brain MRI BrainKey is dedicated to developing AI to examine MRI scans to uncover key biomarkers and assess brain health at a biological level. Get Started Owen Philips, PhD Neuroscientist Founder & CEO “A personal health experience in my own family showed me how difficult it can be for anyone to understand the complex data in their medical images. We created BrainKey to build a tool that empowers people by turning that data into clear, intuitive visualizations of thei
Inception with Owen Phillips, CEO of BrainKey — Social Starts About Portfolio Team Funds Blog Contact LP Portal About Portfolio Team Funds Blog Contact LP Portal February 20, 2020 Social Starts Social Starts Inception with Owen Phillips, CEO of BrainKey Social Starts February 20, 2020 Social Starts Inception with Owen Phillips, CEO of BrainKey Social Starts February 20, 2020 Social Starts Owen Phillips is co-founder and CEO of BrainKey , transforming MRI scans into personal brain dashboards. In this episode, Owen talks about giving people control over the information in their own h … he Way Out? May 12, 2020 Jun 16, 2020 COVID-19 Edition: Enhatch Launches Mobile Application to Allow Medical Device Sales Reps Remote Access into Operating Rooms Jun 16, 2020 Jul 24, 2020 Osano Discovers Direct Relationship Between Poor Privacy Practices and Data Breaches Jul 24, 2020 Nov 9, 2020 Getting Rid of Cash in the Pandemic Age: Introducing i-Accept Nov 9, 2020 Mike Edelhart Dec 14, 2020 Covid and the Winter of Our Discontent Dec 14, 2020 Nov 10, 2020 Quotes to Entrep … Now: Next-Gen Food, Ingredients, and Beverages Feb 12, 2020 Dec 4, 2019 Our New Fund: Social Starts Health and Happiness (SH2) Dec 4, 2019 Oct 30, 2019 Why Do We Invest In Health AND Happiness? Oct 30, 2019 Oct 8, 2019 Quotes to Entrepreneur By: Health and Happiness Oct 8, 2019 Oct 4, 2019 Where We Are Investing Now: Esports and Digital News Oct 4, 2019 Aug 29, 2019 Where We Are Investing Now: Next Gen Food and Drink Aug 29, 2019 Aug 27, 2019 Where We Are Investing Now: Digit … Bad As You Think Jan 4, 2018 Dec 20, 2017 Joyance Partners: A New Member of Our Fund Family Dec 20, 2017 Dec 20, 2017 Words to Entrepreneur By: Part 2 Dec 20, 2017 Dec 15, 2017 The Seven Heavenly Startup Virtues Dec 15, 2017 Dec 10, 2017 The Seven Deadly Startup Sins Dec 10, 2017 Dec 3, 2017 We Honor our Forbes 30 Under 30 Winners Dec 3, 2017 Nov 21, 2017 Truth Nov 21, 2017 Nov 10, 2017 The Philosopher Nov 10, 2017 Nov 6, 2017 We Hold These Truths to be Self-Evident Nov 6, 20 … 0, 2019 Oct 9, 2018 Why We Love Our Work Oct 9, 2018 Oct 5, 2018 What Makes Our Fund Unique? Oct 5, 2018 Sep 18, 2018 Logic and Infrastructure in the Crypto Craze Sep 18, 2018 Aug 16, 2018 Korean Blockchain Startup Demo Day Aug 16, 2018 Jul 31, 2018 Joyance Biotechnology Case Competition Jul 31, 2018 Apr 5, 2018 FutureTech Podcast: Bringing A Dat
Turn Brain Scans into Actionable Insights | BrainKey FAQ Contact Us Log In About Team Partners FAQ Contact Us Log In AI for Brain MRI BrainKey is dedicated to developing AI to examine MRI scans to uncover key biomarkers and assess brain health at a biological level. Get Started Owen Philips, PhD Neuroscientist Founder & CEO “A personal health experience in my own family showed me how difficult it can be for anyone to understand the complex data in their medical images. We created BrainKey to build a tool that empowers people by turning that data into clear, intuitive visualizations of thei
Turn Brain Scans into Actionable Insights | BrainKey FAQ Contact Us Log In About Team Partners FAQ Contact Us Log In AI for Brain MRI BrainKey is dedicated to developing AI to examine MRI scans to uncover key biomarkers and assess brain health at a biological level. Get Started Owen Philips, PhD Neuroscientist Founder & CEO “A personal health experience in my own family showed me how difficult it can be for anyone to understand the complex data in their medical images. We created BrainKey to build a tool that empowers people by turning that data into clear, intuitive visualizations of thei
Turn Brain Scans into Actionable Insights | BrainKey FAQ Contact Us Log In About Team Partners FAQ Contact Us Log In AI for Brain MRI BrainKey is dedicated to developing AI to examine MRI scans to uncover key biomarkers and assess brain health at a biological level. Get Started Owen Philips, PhD Neuroscientist Founder & CEO “A personal health experience in my own family showed me how difficult it can be for anyone to understand the complex data in their medical images. We created BrainKey to build a tool that empowers people by turning that data into clear, intuitive visualizations of thei
Turn Brain Scans into Actionable Insights | BrainKey FAQ Contact Us Log In About Team Partners FAQ Contact Us Log In AI for Brain MRI BrainKey is dedicated to developing AI to examine MRI scans to uncover key biomarkers and assess brain health at a biological level. Get Started Owen Philips, PhD Neuroscientist Founder & CEO “A personal health experience in my own family showed me how difficult it can be for anyone to understand the complex data in their medical images. We created BrainKey to build a tool that empowers people by turning that data into clear, intuitive visualizations of thei
Turn Brain Scans into Actionable Insights | BrainKey FAQ Contact Us Log In About Team Partners FAQ Contact Us Log In AI for Brain MRI BrainKey is dedicated to developing AI to examine MRI scans to uncover key biomarkers and assess brain health at a biological level. Get Started Owen Philips, PhD Neuroscientist Founder & CEO “A personal health experience in my own family showed me how difficult it can be for anyone to understand the complex data in their medical images. We created BrainKey to build a tool that empowers people by turning that data into clear, intuitive visualizations of thei
Turn Brain Scans into Actionable Insights | BrainKey FAQ Contact Us Log In About Team Partners FAQ Contact Us Log In AI for Brain MRI BrainKey is dedicated to developing AI to examine MRI scans to uncover key biomarkers and assess brain health at a biological level. Get Started Owen Philips, PhD Neuroscientist Founder & CEO “A personal health experience in my own family showed me how difficult it can be for anyone to understand the complex data in their medical images. We created BrainKey to build a tool that empowers people by turning that data into clear, intuitive visualizations of thei
Microsoft, BrainKey partner on brain health AI, Google invests $9B in Virginia AI | Anthony K. posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to j … ️⃣ Microsoft + BrainKey for Brain Health AI Microsoft and BrainKey partnered to apply Azure AI for MRI analysis and 3D brain modeling, enhancing early diagnosis. 2️⃣ Google ’s9B AI Expansion in Virginia Google is investing $9 billion to expand its AI and cloud infrastructure in Virginia, alongside local upskilling programs. …more 2 Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in More Relevant Posts Robert Karas, CFA 8mo Edited Report this post ❗
Guest Owen Phillips, CEO of Br… - Inception - Apple Podcasts Search Home New Top Charts Search February 19, 2020 15 min Guest Owen Phillips, CEO of BrainKey Inception Play Owen Phillips is co-founder and CEO of Brainkey, transforming MRI scans into personal brain dashboards. In this episode, Owen talks about giving people control over the information in their own heads; the potential such rich data collection has to develop solutions to diseases like MS, Parkinson’s, and Alzheimers; the profound experience of holding a 3D model of your brain in your hands; opportunities for preventiv
BrainKey - Listen to this podcast with our CEO and... Facebook Log In BrainKey's Post BrainKey October 5, 2020 · Shared with Public Listen to this podcast with our CEO and co-founder Dr. Owen Phillips, about BrainKey’s mission to revolutionize brain health care by helping people access, understand, and benefit from advances in our understanding of the human brain. Find the podcast here: neuralimplantpodcast.com Neural Implant podcast - the people behind Brain-Machine Interface revolutions: Dr. Owen Phillips Discusses How BrainKey Develops 3-D MRI Visualizations Dr. Owen Phillips is the co
Dr. Owen Phillips Discusses How BrainKey Develops 3-D MRI Visualizations - Neural Implant podcast - the people behind Brain-Machine Interface revolutions | Podcast on Spotify
Can we change how our brains age? Scientists think it’s possible Skip to content British Broadcasting Corporation Home News Football 2026 Sport Business Technology Health Culture Arts Travel Earth Audio Video Live Home News US & Canada UK UK Politics England N. Ireland N. Ireland Politics Scotland Scotland Politics Wales Wales Politics Africa Asia China India Australia Europe Latin America Middle East In Pictures BBC InDepth BBC Verify Football 2026 Sport Business World of Business Technology of Business NYSE Opening Bell Technology Artificial Intelligence Intelligence Revolution AI v the
Our brain shape influences how it works, landmark study finds - The University of Sydney Library Current students Staff intranet Find an event Give Contact us Study Research Engage with us About us News & opinion Home / News & opinion / News / June / Our brain shape influences how it works, landmark study finds Home News & opinion News 2026 Arts & culture Business & economics Campus & community Government & politics Health & medicine Law & society Science & technology Subscribe News archive Media contacts Find an expert Find an event Podcasts News_ Our b
BrainKey Careers, Perks + Culture | Built In Companies Jobs Articles Can't find your company? Create a company profile. View All Jobs Join Log In For Employers Companies BrainKey Teams BrainKey Save Saved HQ San Francisco 6 Total Employees Year Founded: 2018 View Website Overview Jobs Offices Is This Your Company? Claim Profile 3D Printing Artificial Intelligence Big Data Healthtech BrainKey’s mission is to revolutionize brain health care. BrainKey is a healthcare startup with a tech core based in San Francisco, USA. Our mission is to revolutionize brain health. We empower people t
BrainKey - Advisory Team | The Org Platform Enrich Pricing Log in Sign up BrainKey Teams Advisory Team Unverified Advisory Team 5 people · 0 jobs The Advisory Team at BrainKey provides strategic guidance and expertise to shape the company's efforts in improving diagnostics, treatment, and monitoring of dementia. Comprised of industry experts and led by a Scientific Advisor & Head of Product Development, they play a crucial role in ensuring the scientific accuracy and effectiveness of BrainKey's innovative solutions. People ( 5 ) AC Akshay Chaudhari Advisor EK Edmond Knopp Advis
BrainKey: Brain Longevity | Y Combinator Open menu About What Happens at YC? Apply YC Interview Guide FAQ People YC Blog Companies Startup Directory Founder Directory Launch YC Library Partners Resources Startup School Newsletter Requests for Startups For Investors Verify Founders Hacker News Bookface Safe Find a Co-Founder Startup Jobs Log in Apply Home › Companies › BrainKey BrainKey Brain Longevity Y Combinator Logo Winter 2019 Active Neurotechnology Health Tech Digital Health AI San Francisco Company Jobs 0 News https://www.brainkey.ai/ Brain Longevity BrainKey is an AI-driven digital heal
BrainKey San Francisco Jobs + Careers | Built In San Francisco San Francisco Global Tech Hub BuiltIn.com is the global destination for tech professionals. builtin.com Popular Tech Hubs United States Austin Boston Chicago Colorado Los Angeles New York City Seattle San Francisco Australia Sydney Melbourne Canada Calgary Montreal Ottawa Quebec Toronto Vancouver India Bengaluru Chennai Delhi Hyderabad Kolkata Mumbai Pune Ireland Dublin Singapore Singapore United Kingdom London Cambridge Manchester Birmingham Bristol Companies Jobs Articles Can't find your company? Create a company profile. Vi
BrainKey Scan at Harley Street - UME Health Skip to content 0207 467 6190 --> 17 Harley Street, London For Healthcare Professionals Request appointment Health Services Abdomen Pain Clinic Cardiology Cardiovascular Autonomic Function Lab Ear, Nose, and Throat (ENT) Echocardiogram Hydrogen Breath Test Orthopaedic, Spinal, Musculoskeletal & Sports Medicine Paediatrics Platelet-Rich Plasma (PRP) Injection Podiatry Radiofrequency Ablation (RFA) Speech & Language Therapy Diagnostics CT (Computerised Tomography) FibroScan MRI (Magnetic Resonance Imaging) X-Ray Scan Patient Friendly MRI Scan U … irculation and relieve tension in the abdominal area. Another helpful tip is to apply a warm compress or take a warm bath to soothe abdominal discomfort. The warmth can help relax the muscles and alleviate pain. However, it's important to consult with a healthcare provider before trying any new remedies or techniques during pregnancy. Make sure to get enough rest and drink plenty of fluids to stay hydrated and maintain your overall well-being throughout your pregnancy. What c
Cyber Valley expands start-up and investor networks English Login Passwort vergessen? Registrieren Kontakt idw – Informationsdienst Wissenschaft Nachrichten, Termine, Experten Navigation --- Angebote --- Nachrichten Termine Experten Bilder Social Media --- Mein idw --- Login Registrieren --- Über den idw --- Wer wir sind Mitgliedschaft Mitgliederverzeichnis Qualitätssicherung idw-Preis --- Service --- Kontakt Einführung English FAQ Impressum Erste Schritte Einführung Recherche Publizieren FAQ Über den idw Wer wir sind Mitgliedschaft Mitgliederverzeichnis In eigener Sache idw-Kanäle Quali … relates not only to artificial intelligence research, but also to the concrete application of modern AI technologies – including in the areas of health and climate protection, as the latest additions impressively demonstrate.” BrainKey quantifies brain health and align patients with the right treatment. For that, multimodal data fusion is used on biomedical data such as genetic and imaging data in order to assess brain health and provide treatment recommendations. “We create
Turn Brain Scans into Actionable Insights | BrainKey FAQ Contact Us Log In About Team Partners FAQ Contact Us Log In AI for Brain MRI BrainKey is dedicated to developing AI to examine MRI scans to uncover key biomarkers and assess brain health at a biological level. Get Started Owen Philips, PhD Neuroscientist Founder & CEO “A personal health experience in my own family showed me how difficult it can be for anyone to understand the complex data in their medical images. We created BrainKey to build a tool that empowers people by turning that data into clear, intuitive visualizations of thei
Cyber Valley expands start-up and investor networks | Cyber Valley --> EN News About Events News Public engagement Jobs Start-up Network Corporate Network Investor Network The AI Incubator Health Cluster All News 30 September 2022 | Stuttgart/Tübingen Cyber Valley expands start-up and investor networks AI ecosystem in Germany’s southwest continues to grow The Cyber Valley Start-up Network is growing: With BrainKey, Concular and TREEO, three more young companies have joined the community of innovative AI start-ups. The Cyber Valley Start-up Network now has 36 members. In addition, Europe’s larg … relates not only to artificial intelligence research, but also to the concrete application of modern AI technologies – including in the areas of health and climate protection, as the latest additions impressively demonstrate.” BrainKey quantifies brain health and align patients with the right treatment. For that, multimodal data fusion is used on biomedical data such as genetic and imaging data in order to assess brain health and provide treatment recommendations. “We create … e IMPRS-IS Cyber Valley Innovation Campus Research Groups Cyber Valley Research Fund --> Cyber Valley GmbH Innovation & Economy Cyber Valley Start-up Network Cyber Valley Corporate Network Cyber Valley Investor Network Public engagement --> Public Advisory Board About Cyber Valley Community Cyber Valley Innovation Campus 1.0 Cyber Valley GmbH Team Cyber Valley GmbH Values Cyber Valley GmbH Supervisory Board Cyber Valley GmbH Media Relations Cyber Valley Community FAQs Sig
BrainKey – turning brain scans and genetic data into brain health insights Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Leal Therapeutics
BrainKey and Microsoft Azure: Advancing brain health research with responsible AI - Microsoft for Startups Blog Skip to content Skip to main content Microsoft for Startups Support Blog Success Stories Investor information Specialty programs Get started Sign in Microsoft 365 Azure Copilot Windows Surface XBOX Deals Small Business Support Windows Apps Outlook OneDrive Microsoft Teams OneNote Microsoft Edge Moving from Skype to Teams Computers Shop XBOX Accessories VR & mixed reality Certified Refurbished Trade-in for cash XBOX Game Pass Ultimate PC Game Pass XBOX games PC games Microsoft AI
Nathan Strong - AI Development Lead at BrainKey | The Org Platform Enrich Pricing Log in Sign up BrainKey Nathan Strong Unverified Nathan Strong AI Development Lead Contact Nathan Strong is currently the AI Development Lead at BrainKey. Prior to this, they were with the San Francisco Public Utilities Commission and Terroir AI. Nathan has also worked as a Graduate Teaching Affiliate and Research Assistant at Stanford University. Nathan has always been interested in pathogens and disinfection and how to make a positive impact in their communities. As a Laboratory Safety Officer at Stanford, th
Extracting interpretable signatures of whole-brain dynamics through systematic comparison Extracting interpretable signatures of whole-brain dynamics through systematic comparison bioRxiv [Preprint] . 2024 Jun 10:2024.01.10.573372. doi: 10.1101/2024.01.10.573372. Authors Annie G Bryant 1 , Kevin Aquino 1 2 , Linden Parkes 3 4 , Alex Fornito 4 , Ben D Fulcher 1 Affiliations 1 School of Physics, The University of Sydney, Camperdown, NSW, Australia. 2 Brain Key Incorporated, San Francisco, CA, USA. 3 Department of Psychiatry … that alternative dynamical properties may outperform those reported for a given application. Here, we address this limitation by systematically comparing diverse, interpretable features of both intra-regional activity and inter-regional functional coupling from resting-state functional magnetic resonance imaging (rs-fMRI) data, demonstrating our method using case-control comparisons of four neuropsychiatric disorders. Our findings generally support the use of linear time-seri
Extracting interpretable signatures of whole-brain dynamics through systematic comparison | PLOS Computational Biology Skip to main content Advertisement PLOS Computational Biology Browse Current Issue Journal Archive Collections Find and Read Articles Publish Submissions Getting Started Submission Guidelines Figures Tables Supporting Information LaTeX Other Article Types Preprints Revising Your Manuscript Submit Now Policies Best Practices in Research Reporting Human Subjects Research Animal Research Competing Interests Disclosure of Funding Sources Licenses and Copyright Data Availability Co … that alternative dynamical properties may outperform those reported for a given application. Here, we address this limitation by systematically comparing diverse, interpretable features of both intra-regional activity and inter-regional functional coupling from resting-state functional magnetic resonance imaging (rs-fMRI) data, demonstrating our method using case–control comparisons of four neuropsychiatric disorders. Our findings generally support the use of linear time-seri … National Institute Of Mental Health of the National Institutes of Health under Award Number R00MH127296 ( https://www.nimh.nih.gov/funding/training/nih-pathway-to-independence-award-k99-r00 ). The funder did not play any role in study design, data collection and analysis, decision to publish, or preparation in the manuscript. Competing interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: K.A. is an employee an … ries feature approaches can distill the most informative biomarkers for a given application, such as distinguishing fMRI scans obtained at rest vs while watching a film [ 25 ] or comparing neurophysiological dynamics with cortical microarchitecture [ 32 ] or structural connectivity [ 33 ]. Importantly, time-series analysis methods developed outside of the neuroimaging space (such as dynamic time warping, originally developed for spoken word recognition [ 34 ]) have been shown … two moments of a time series distribution can be highly informative in a given application [ 106 ]—and fALFF as a benchmark statistic for localized rs-fMRI dynamics [ 19 , 107 ]. Inter-regional FC was summarized using 14 statistics for pairwise interactions (SPIs) derived as a representative subset from an initial library of over 200 candidate S
Brainkey — Whiteford Research Biobase Company DB ← Company DB Company information is AI generated, and may be inaccurate. BrainKey Overview BrainKey is a San Francisco-based digital health company building AI software for brain MRI interpretation and brain-health assessment. The company describes its product as "AI for Brain MRI" and says it examines MRI scans to uncover biomarkers and assess brain health at a biological level. [1] Y Combinator lists BrainKey as a Winter 2019 company founded in 2018, active, with a mission to create a world free from dementia. [2] Technology BrainKey focuses o
Shoutout to BrainKey's CSO Kevin Aquino, Ph.D. He's amazing! He spoke at the Sydney University graduation ceremony today. | Owen Phillips, Ph.D. LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedI
(hypr)��Ʊ��˾�߹�_����_���˲ƾ�_������ �ƾ���ҳ | ������ҳ | ���˵��� ����˹ -----.-- ----.-- | ��˹��� ----.-- ---.-- | ����ʱ�� | ��������ʱ�� ������� ���� --> .shtml">�鿴��������ҳ>> | ���ҵ�λ:��Ԫ(USD) Hyperfine, Inc. (hypr) ʵʱ (?) : �̺� (?) : ��ȡ��... -- (--%) ���̼�:-- ���:-- ��ͼ�:-- 52�����:-- 52����ͼ�:-- �ɽ���:-- ƽ���ɽ���:-- ��ֵ:-- ��ӯ��:-- Ԥ����ӯ��:-- ÿ������:-- ����ϵ��:-- ��Ϣ:-- ������:-- �ܹɱ�:-- ��ʾ:������ ��˾ժҪ ��˾�߹� ��˾���� �߹ܽ���״�� �ֹ�״�� ����� �ʲ���ծ�� �ֽ������� Robert Fasciano Robert Fasciano is currently Chief Regulatory & Quality Officer at Hyperfine, Inc. since 2
Algirdas Avižienis - Google Scholar Loading... The system can't perform the operation now. Try again later. Citations per year Duplicate citations The following articles are merged in Scholar. Their combined citations are counted only for the first article. Merged citations This "Cited by" count includes citations to the following articles in Scholar. The ones marked * may be different from the article in the profile. Add co-authors Co-authors Follow New articles by this author New citations to this author New articles related to this author's research Email address for updates Do … 1-58 , 1997 293 1997 Arithmetic error codes: Cost and effectiveness studies for application in digital system design A Avizienis IEEE Transactions on computers 100 (11), 1322-1331 , 1971 240 1971 Reliability analysis and architecture of a hybrid-redundant digital system: Generalized triple modular redundancy with self-repair FP Mathur, A Avižienis Proceedings of the May 5-7, 1970, spring joint computer conference, 375-383 , 1970 174 1970 Fault-tolerant design for VLSI: e
About | BrainKey FAQ Contact Us Log In About Team Partners FAQ Contact Us Log In About Us BrainKey's Mission At BrainKey, we’re harnessing the power of AI and advanced clinical technologies to provide personalized brain health insights through brain MRI and biomedical analysis. Our mission is clear: to equip physicians with the tools they need to prevent cognitive decline and create a world where dementia no longer threatens 1 in 3 of us. My family’s experience with a difficult health journey highlighted for me just how challenging it can be to interpret complex medical imaging. The data was t